Pages that link to "Q39960772"
Jump to navigation
Jump to search
The following pages link to The side population of ovarian cancer cells is a primary target of IFN-alpha antitumor effects. (Q39960772):
Displaying 50 items.
- Interferon after surgery for women with advanced (Stage II-IV) epithelial ovarian cancer (Q24202094) (← links)
- Interferon after surgery for women with advanced (Stage II-IV) epithelial ovarian cancer (Q24203808) (← links)
- Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities (Q26828930) (← links)
- Emerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approach (Q26849477) (← links)
- Regulation of ovarian cancer stem cells or tumor-initiating cells (Q26853096) (← links)
- Interferons as inducers of apoptosis in malignant cells (Q27010207) (← links)
- Drug-tolerant cancer cells show reduced tumor-initiating capacity: depletion of CD44 cells and evidence for epigenetic mechanisms (Q28477091) (← links)
- Flow cytometry analysis of murine hematopoietic stem cells (Q30539301) (← links)
- The multiple facets of drug resistance: one history, different approaches (Q33697116) (← links)
- Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications (Q33820610) (← links)
- New promising drug targets in cancer- and metastasis-initiating cells (Q34003691) (← links)
- Factors influencing the abundance of the side population in a human myeloma cell line. (Q34064941) (← links)
- Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancer (Q34137275) (← links)
- Side population cells from human melanoma tumors reveal diverse mechanisms for chemoresistance (Q34279342) (← links)
- The side population of ovarian cancer cells defines a heterogeneous compartment exhibiting stem cell characteristics (Q34334489) (← links)
- TWIST and ovarian cancer stem cells: implications for chemoresistance and metastasis (Q34365639) (← links)
- Novel therapies against aggressive and recurrent epithelial cancers by molecular targeting tumor- and metastasis-initiating cells and their progenies (Q34382586) (← links)
- ABCG2 protects kidney side population cells from hypoxia/reoxygenation injury through activation of the MEK/ERK pathway (Q34432586) (← links)
- Ovarian cancer stem cells express ROR1, which can be targeted for anti-cancer-stem-cell therapy (Q34448718) (← links)
- Cancer stem cells and epithelial ovarian cancer (Q34557441) (← links)
- Ovarian cancer stem cell-like side populations are enriched following chemotherapy and overexpress EZH2. (Q34569371) (← links)
- CSNK1α1 mediates malignant plasma cell survival (Q34774056) (← links)
- Cancer stem cells and side population cells in breast cancer and metastasis. (Q35038054) (← links)
- Ovarian cancer stem cells: are they real and why are they important? (Q35047699) (← links)
- Immunotherapy for ovarian cancer. (Q35164189) (← links)
- Reversing paclitaxel resistance in ovarian cancer cells via inhibition of the ABCB1 expressing side population (Q35200985) (← links)
- CD133+ ovarian cancer stem-like cells promote non-stem cancer cell metastasis via CCL5 induced epithelial-mesenchymal transition (Q35742418) (← links)
- The conserved Cockayne syndrome B-piggyBac fusion protein (CSB-PGBD3) affects DNA repair and induces both interferon-like and innate antiviral responses in CSB-null cells. (Q35923273) (← links)
- Drug Transporter-Mediated Protection of Cancer Stem Cells From Ionophore Antibiotics (Q35975423) (← links)
- Maintenance therapy in ovarian cancer: Molecular basis and therapeutic approach (Q36230572) (← links)
- Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research. (Q36358324) (← links)
- Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy (Q36378255) (← links)
- Transformation of epithelial ovarian cancer stemlike cells into mesenchymal lineage via EMT results in cellular heterogeneity and supports tumor engraftment (Q36434358) (← links)
- TLR2 enhances ovarian cancer stem cell self-renewal and promotes tumor repair and recurrence (Q36654413) (← links)
- Therapeutic strategies targeting cancer stem cells (Q36887716) (← links)
- The duplicitous origin of ovarian cancer (Q36919484) (← links)
- Constitutive proteasomal degradation of TWIST-1 in epithelial-ovarian cancer stem cells impacts differentiation and metastatic potential (Q36989636) (← links)
- Intratunical Injection of Genetically Modified Adipose Tissue-Derived Stem Cells with Human Interferon α-2b for Treatment of Erectile Dysfunction in a Rat Model of Tunica Albugineal Fibrosis (Q37021450) (← links)
- Pancreatic cancer stem cells: new understanding of tumorigenesis, clinical implications (Q37473148) (← links)
- Cancer stem cells: a reality, a myth, a fuzzy concept or a misnomer? An analysis (Q37621777) (← links)
- Identification of epithelial stromal interaction 1 as a novel effector downstream of Krüppel-like factor 8 in breast cancer invasion and metastasis (Q37691895) (← links)
- Resistance to glucose starvation as metabolic trait of platinum-resistant human epithelial ovarian cancer cells. (Q37701616) (← links)
- Identification of an atypical etiological head and neck squamous carcinoma subtype featuring the CpG island methylator phenotype (Q37714302) (← links)
- Immune Therapy for Ovarian Cancer: Promise and Pitfalls (Q37873928) (← links)
- Ovarian cancer stem cells: elusive targets for chemotherapy (Q38013671) (← links)
- Tumor stem cells: A new approach for tumor therapy (Review). (Q38030535) (← links)
- Cancer stem cells in pediatric sarcomas (Q38118769) (← links)
- Investigating molecular profiles of ovarian cancer: an update on cancer stem cells. (Q38203882) (← links)
- Concise Review: Emerging Drugs Targeting Epithelial Cancer Stem-Like Cells (Q39112034) (← links)
- Interferon regulatory factor (IRF)-1 and IRF-2 are associated with prognosis and tumor invasion in HCC. (Q39313078) (← links)